• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE GENUS; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE GENUS; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-1216
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Urinary Incontinence (4572)
Event Date 09/21/2021
Event Type  Injury  
Event Description
It was reported that the patient, that is enrolled in the (b)(6) clinical trial, experienced a serious adverse event of urge incontinence which was mild in severity.The patient was given medication and was hospitalized.The event resolved a week and a half later.The event was assessed as not related to the procedure or the device itself.The event was assessed as having a possible relationship to the stimulation.
 
Event Description
It was reported that the patient, that is enrolled in the a4012 clinical trial, experienced a serious adverse event of urge incontinence which was mild in severity.The patient was given medication and was hospitalized.The event resolved a week and a half later.The event was assessed as not related to the procedure or the device itself.The event was assessed as having a possible relationship to the stimulation.Additional information was received that the relationship to the stimulation was updated to unlikely.Database analysis was completed and confirmed that the device is operating as expected.
 
Event Description
It was reported that the patient, that is enrolled in the a4012 clinical trial, experienced a serious adverse event of urge incontinence which was mild in severity.The patient was given medication and was hospitalized.The event resolved a week and a half later.The event was assessed as not related to the procedure or the device itself.The event was assessed as having a possible relationship to the stimulation.Additional information was received that the relationship to the stimulation was updated to unlikely.Database analysis was completed and confirmed that the device is operating as expected.Additional information was received stating that the event was updated to indicate that the relationship to procedure was reported as possible.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE GENUS
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
talar tahmasian
25155 rye canyon loop
valencia, CA 91355
6619494863
MDR Report Key12734389
MDR Text Key279517720
Report Number3006630150-2021-06141
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729985044
UDI-Public08714729985044
Combination Product (y/n)N
Reporter Country CodeBE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date05/10/2023
Device Model NumberDB-1216
Device Catalogue NumberDB-1216
Device Lot Number511159
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/20/2021
Initial Date FDA Received11/02/2021
Supplement Dates Manufacturer Received12/15/2021
02/25/2022
Supplement Dates FDA Received01/12/2022
03/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age74 YR
Patient SexMale
-
-